—  Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported earnings of $2.71 per share in the fourth-quarter 2019, vs. $2.60 per share expected. — Total revenue rose 23% to $1.38 billion, vs. $1.31 billion expected. SOLIRIS net sales rose 11% to $3.94 billion. — For FY20, Alexion expects revenues of $5.50 – $5.56 billion. Adjusted EPS is … Continue reading Alexion Pharmaceuticals, Inc. (ALXN): Earnings Snapshot